052260 — Hyundai BioLand Co Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousSmall CapNeutral

Annual cashflow statement for Hyundai BioLand Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	10,849	-13,545	-11,686	4,764	8,056
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	1,397	9,517	27,031	5,886	146
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-7,801	6,405	-2,454	-5,690	-8,915
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	11,353	8,959	21,476	11,312	5,588
Capital Expenditures	-22,063	-7,591	-3,351	-4,752	-6,290
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	713	-405	1,104	-13,734	12,528
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-21,350	-7,995	-2,247	-18,487	6,238
Financing Cash Flow Items	-797	-1,515	-1,355	-1,278	-1,516
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities	3,776	-4,808	-14,892	314	-5,697
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-6,232	-3,933	4,361	-7,095	5,956